Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. (EKSO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EKSO · as of Jun 9, 2026
Key Statistics
Explore Ekso Bionics Holdings, Inc. Data
ekso stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The EKSO analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $3.50, representing -70.34% downside from the current price of $11.80.
Competitors & Peers
ekso competitorsEKSO
AEMD
ALUR
ANL
AYTU
CODXStock Performance
Full HistoryAbout Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. is a global innovator in exoskeleton technology, specializing in the creation, production, sale, and leasing of these advanced devices across the Americas, Europe, the Midd…
what is ekso bionics holdings, inc. · ekso stock overview · ekso bionics holdings, inc. company profile · who is ekso bionics holdings, inc. ceo · ekso NASDAQ · ekso bionics holdings, inc. headquarters · ekso bionics holdings, inc. business segments
About Stock Overview & Key Data
Ekso Bionics Holdings, Inc. (EKSO) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Jan 17, 2014. As of the latest trading session, EKSO stock price is $11.80, with a market capitalization of $28.6M. The stock has returned +173.78% over the past 12 months and +36.57% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Ekso Bionics Holdings, Inc. stock is Buy, with an average 12-month price target of $3.50. In fiscal year 2025, Ekso Bionics Holdings, Inc. reported revenue of $12.8M and net income of -$11.7M. For detailed data — including Ekso Bionics Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ekso Bionics Holdings, Inc. (EKSO) stock price is $11.80. The stock is traded on NASDAQ under the ticker symbol EKSO. The 52-week range is $2.73 – $13.50.